You have probably read the news by now -- but do you recall the most remarkable rates of decline? Was it in MI? Lower-limb amputations? Death after hyperglycemic crisis? Check your memory with this quick quiz.
The benefits of statin therapy no longer stand uncontested as they did early in the lifecycle of the class. The pro and con camps each can point to science, but in the end it's about personalized medicine.
The patient, an active 49-year-old man, had an HbA1c of 8.6 after diabetes was first diagnosed. It’s now 7.6 with metformin and lifestyle measures. Is the current A1c goal adequate, or should you treat more aggressively?
Achieving sustained reductions of hyperlipidemia and blood pressure in a patient with diabetes is not impossible, but it's a challenge. A new study comparing two health systems shows which factors increase the odds of success.